The Rising Incidences Of Seasonal Influenza Drive Growth In The Influenza Vaccine Market Driving Market Acceleration in the Influenza Vaccines Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Influenza Vaccines Market Size By 2025?
In the past few years, the influenza vaccines market has seen robust growth. The market size is expected to surge from $8.5 billion in 2024 to $9.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The incremental growth during the historic period is ascribed to factors such as readiness for pandemics, public health drives, research on vaccine efficiency, suggestions from healthcare experts, and global surveillance of influenza.

How Big Is the Influenza Vaccines Market Size Expected to Grow by 2029?
The size of the influenza vaccines market is forecasted to experience robust growth in the upcoming years, escalating to "$12.13 billion in 2029 with a compound annual growth rate (CAGR) of 7.6%. The escalation for the predicted period is attributable to elements such as climatic and environmental considerations, enhancement in healthcare accessibility, introduction of new influenza variants, innovation in adjuvants and delivery ecosystems, and an increase in healthcare expenditure. Noteworthy trends during the prediction period comprise the broader application of mRNA vaccine technology, emphasis on pediatric immunization, initiatives to manage seasonal influenza, expanded vaccination coverage in developing countries, and customized vaccination plans.

View the full report here:
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Key Market Drivers Powering Influenza Vaccines Market Expansion and Growth?
The increase in seasonal influenza cases is predicted to drive the growth of the influenza vaccine market in the future. Seasonal influenza is a respiratory disease caused by the influenza viruses that commonly circulate and infect people during certain times of the year, specifically during the colder months. Factors such as antigenic drift, susceptibility in the population, environmental elements, insufficient vaccine coverage, and absence of universal vaccination have contributed to this shift. The job of influenza vaccines is to decrease the occurrence of seasonal influenza by protecting against the strains of the virus that are in circulation. For instance, the US government agency, the Centers for Disease Control and Prevention (CDC), stated in November 2023 that during the 2022-2023 flu season, there were an estimated 31 million cases of flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospital admissions, and 21,000 flu-related fatalities. Thus, the increasing cases of seasonal influenza are fueling the expansion of the influenza vaccines market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Influenza Vaccines Market?
The rise of sophisticated vaccine manufacturing practices is rapidly becoming a significant trend in the influenza vaccine market. Companies involved in this market are utilizing cutting-edge vaccine production techniques to maintain their market standing. For example, in January 2023, GlaxoSmithKline PLC, a pharmaceutical and biotechnical firm from the UK, launched MAPS - Multiple Antigen Presenting System for vaccine development. This innovative method is revolutionizing how vaccines are developed to combat bacteria and viruses. Crucially, it is beneficial for swiftly developing vaccines in response to epidemic or pandemic outbreaks.

What Are the Emerging Segments in the Influenza Vaccines Market?
The influenza vaccines market covered in this report is segmented -

1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

Who Are the Global Leaders in the Influenza Vaccines Market?
Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Which are the Top Profitable Regional Markets for the Influenza Vaccines Industry?
North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.